These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2498958)

  • 1. Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
    Friston KJ; Sharpley AL; Solomon RA; Cowen PJ
    Psychopharmacology (Berl); 1989; 98(1):139-40. PubMed ID: 2498958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra.
    Landolt HP; Meier V; Burgess HJ; Finelli LA; Cattelin F; Achermann P; Borbély AA
    Neuropsychopharmacology; 1999 Sep; 21(3):455-66. PubMed ID: 10457543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
    Loas G
    Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
    Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
    Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment.
    Sharpley AL; Gregory CA; Solomon RA; Cowen PJ
    J Affect Disord; 1990 Aug; 19(4):273-7. PubMed ID: 2146304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade.
    Seifritz E; Moore P; Trachsel L; Bhatti T; Stahl SM; Gillin JC
    Neurosci Lett; 1996 May; 209(1):41-4. PubMed ID: 8734905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
    da Roza Davis JM; Sharpley AL; Solomon RA; Cowen PJ
    J Affect Disord; 1992 Mar; 24(3):177-81. PubMed ID: 1573126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of lithium carbonate on the sleep-waking cycle in the cat.
    Lanoir J; Lardennois D
    Electroencephalogr Clin Neurophysiol; 1977 May; 42(5):676-90. PubMed ID: 67027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and the electroencephalogram during sleep.
    Brebbia DR; Altshuler KZ; Kline NS
    Dis Nerv Syst; 1969 Aug; 30(8):541-6. PubMed ID: 4309277
    [No Abstract]   [Full Text] [Related]  

  • 14. Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat.
    Dugovic C; Leysen JE; Wauquier A
    Neurosci Lett; 1989 Oct; 104(3):320-5. PubMed ID: 2510097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lithium carbonate on the sleep of depressed patients.
    Mendels J; Chernik DA
    Int Pharmacopsychiatry; 1973; 8(3):184-92. PubMed ID: 4373405
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
    Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
    Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.
    da Roza Davis JM; Sharpley AL; Cowen PJ
    Psychopharmacology (Berl); 1992; 108(3):387-9. PubMed ID: 1523288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
    Idzikowski C; Mills FJ; Glennard R
    Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysis.
    Solomon RA; Sharpley AL; Cowen PJ
    J Psychopharmacol; 1989 Jan; 3(3):125-9. PubMed ID: 22282895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.